DTC black.png
Discovery Therapeutics Caribe Receives Study May Proceed Letter from FDA to initiate a Phase 3 Clinical Trial of intralesional rhEGF for the treatment of diabetic foot ulcers
April 30, 2024 09:00 ET | Discovery Therapeutics Caribe, LLC
FDA approves Discovery Therapeutic Caribe's Phase 3 trial for intralesional rhEGF in severe diabetic foot ulcers.
FSR_ClevelandClinicEventPhoto
26 Patient Volunteer Leaders Attend the Foundation for Sarcoidosis Research Global Sarcoidosis Clinic Alliance Volunteer Patient Leadership Advanced Training Conference held at Cleveland Clinic
March 27, 2024 06:41 ET | Foundation for Sarcoidosis Research
26 Patient Volunteer Leaders joined the Foundation for Sarcoidosis Research at Cleveland Clinic for the Leadership Advanced Training Conference
FSR Logo-Black Horizontal Title_bolder.png
Foundation for Sarcoidosis Research Partners to Host 30 Volunteer Patient Leaders at Unique In-Person Training at Cleveland Clinic
March 01, 2024 10:35 ET | Foundation for Sarcoidosis Research
FSR to host in-person training of Volunteer Patient Leaders from around the United States at Cleveland Clinic.
Cleveland Clinic and
Cleveland Clinic and Canon Inc. Enter Partnership to Advance Global Innovation in Medical Imaging Solutions
November 27, 2023 10:02 ET | Canon U.S.A., Inc.
Cleveland, OH, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Cleveland Clinic and Canon Inc. have announced intentions to form a strategic research partnership to develop innovative imaging and healthcare IT...
SPR Therapeutics LOGO 361 TM.jpg
SPR Therapeutics Named a Top Workplace for Second Consecutive Year
June 25, 2023 08:00 ET | SPR Therapeutics, Inc.
- Company maintains focus on employee engagement and success while experiencing dynamic growth - CLEVELAND, June 25, 2023 (GLOBE NEWSWIRE) -- SPR Therapeutics has been selected as a Top...
visiongain Logo.png
Biodefence Market is projected to grow at a CAGR of 7.78% by 2033: Visiongain Reports Ltd
February 21, 2023 11:36 ET | Visiongain Reports Ltd
Visiongain has published a new report entitled Biodefence Market 2023-2033. It includes profiles of Biodefence Market and Forecasts, Market Segment by Size by Product (Vaccines {Anthrax, Smallpox,...
ReportLinker logo.jpg
Global Biodefense Market to Reach $19 Billion by 2030
February 16, 2023 09:57 ET | ReportLinker
New York, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Biodefense Industry" - https://www.reportlinker.com/p05961247/?utm_source=GNW Food and fuel...
Future Market Insights.png
Biodefense Market Sales are Estimated to Cross US$ 32.99 billion by 2033, Rise in Sales for Vaccines Surges the Demand for Biodefense | Future Market Insights, Inc.
February 15, 2023 19:30 ET | Future Market Insights Global and Consulting Pvt. Ltd.
DUBAI, United Arab Emirates, Feb. 15, 2023 (GLOBE NEWSWIRE) -- It is estimated that the Biodefense Market is anticipated to reach US$ 32.99 billion by 2033 after being valued at US$ 16.31 billion in...
Greenwave.png
Greenwave Secures Property for Metal Recycling Facility in Cleveland, Ohio
February 15, 2023 13:22 ET | Greenwave Technology Solutions, Inc.
CHESAPEAKE, Va., Feb. 15, 2023 (GLOBE NEWSWIRE) -- Greenwave Technology Solutions, Inc. ("Greenwave" or the "Company") (NASDAQ: GWAV), a leading operator of metal recycling facilities in Virginia,...
ReportLinker logo.jpg
Biodefence Market Report 2023-2033
January 23, 2023 09:55 ET | ReportLinker
New York, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Biodefence Market Report 2023-2033" - https://www.reportlinker.com/p06383482/?utm_source=GNW The...